Page last updated: 2024-11-08

potassium nitrite

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID516910
CHEMBL ID3186418
MeSH IDM0122652

Synonyms (43)

Synonym
epa pesticide chemical code 076203
potassium nitrite (1:1)
nitrous acid, potassium salt
hsdb 1216
einecs 231-832-4
ccris 3959
un1488
caswell no. 698
potassium nitrite
794654g42l ,
potassium nitrite [un1488] [oxidizer]
7758-09-0
nitrous acid, potassium salt (1:1)
unii-794654g42l
dtxcid3022320
cas-7758-09-0
dtxsid5042320 ,
tox21_301322
NCGC00255971-01
FT-0689071
ins no.249
potassium nitrite [fcc]
e-249
ins-249
nitrous acid potassium salt (1:1)
potassium nitrite [hsdb]
potassium nitrite [mi]
e249
AKOS015853609
BXNHTSHTPBPRFX-UHFFFAOYSA-M
92937-66-1
CHEMBL3186418
mfcd00011408
potassium nitrite, acs reagent, >=96.0%
potassium nitrite, meets analytical specification of fcc, 97-100.5%
potassium nitrite, ~97% (titration)
potassium nitrite, p.a., 97%
kaliumnitrit
potassium nitrite, acs grade
Q409179
potassium;nitrite
potassium nitrite (15n)
potassium nitrite (kno2)

Research Excerpts

Overview

Potassium nitrite is an effective urine adulterant due to its oxidizing potential. It has been shown to mask the presence of many drugs of abuse.

ExcerptReferenceRelevance
"Potassium nitrite is an effective urine adulterant due to its oxidizing potential, and has been shown to mask the presence of many drugs of abuse."( Detection and identification of 2-nitro-morphine and 2-nitro-morphine-6-glucuronide in nitrite adulterated urine specimens containing morphine and its glucuronides.
Fu, S; Luong, S, 2014
)
1.12

Bioavailability

ExcerptReferenceRelevance
" Based on a parallel line assay, the relative bioavailability of folate in the brewers yeast diet (109) was significantly higher than in the standard diet (PGA = 100)."( Effect of nitrite ingestion on the bioavailability of folate in the rat.
Hoppner, K; Lampi, B, 1992
)
0.28
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (17 Items)

ItemProcessFrequency
Meats and their productscore-ingredient6
Meatscore-ingredient5
Prepared meatscore-ingredient4
Smoked baconcore-ingredient2
Baconcore-ingredient2
Porkcore-ingredient2
Cured meatcore-ingredient1
Chorizocore-ingredient1
Cured sausagescore-ingredient1
Saladscore-ingredient1
Prepared saladscore-ingredient1
Mealscore-ingredient1
Chicken and ham gratincore-ingredient1
Smoked back baconcore-ingredient1
Bacon rasherscore-ingredient1
Back baconcore-ingredient1
Sausagescore-ingredient1

Protein Targets (2)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
GLI family zinc finger 3Homo sapiens (human)Potency2.73060.000714.592883.7951AID1259369
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency58.57370.003041.611522,387.1992AID1159552; AID1159555
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (28)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (17.86)18.7374
1990's5 (17.86)18.2507
2000's9 (32.14)29.6817
2010's9 (32.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 58.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index58.64 (24.57)
Research Supply Index3.47 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index94.94 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (58.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (3.33%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other29 (96.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]